SCHEMBL8856569

SCHEMBL8856569

Cc1cccc(NN=c2c(=O)c3ccccc3c2=O)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.60
SMN1; SMN2 Q16637 6/20 0.60
NPC1 O15118 6/20 0.60
RAB9A P51151 6/20 0.60
KDM4E B2RXH2 1/20 0.58
ATM Q13315 1/20 0.58
KMT2A Q03164 7/20 0.55
MEN1 O00255 6/20 0.55
ALDH1A1 P00352 4/20 0.55
LMNA P02545 1/20 0.47
NPSR1 Q6W5P4 1/20 0.44
SENP8 Q96LD8 2/20 0.44
SENP7 Q9BQF6 2/20 0.44
SENP6 Q9GZR1 2/20 0.44
HPGD P15428 1/20 0.42
MAOB P27338 1/20 0.42
MAPK1 P28482 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HSD17B10 Q99714 1/20 0.41
CYP1A2 P05177 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8856597 0.81 MAPT (0.62) MAPTSMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL8856756 0.81 MAPT (0.54) MAPTSMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL9004666 0.80 KMT2A (0.52) MAPTSMN1; SMN2NPC1RAB9AKMT2A
Water SCHEMBL9571731 0.79 KMT2A (0.51) MAPTSMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL8856708 0.77 MAPT (0.56) MAPTSMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL8856417 0.73 SMN1; SMN2 (0.70) MAPTSMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL8856938 0.71 MAPT (0.56) MAPTSMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL8856666 0.71 SENP6 (0.61) MAPTSMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL8856560 0.70 MAPT (0.68) MAPTSMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL8856529 0.68 SMN1; SMN2 (0.44) MAPTSMN1; SMN2NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5648381-A Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof INNOTHERA (FR) 1997-07-15 US disclosed
EP-0566446-B1 Derivatives of indane-1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA LAB SA (FR) 1996-02-07 EP disclosed
EP-0566446-A1 Derivatives of indane-1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA (FR) 1993-10-20 EP disclosed
WO-1993020046-A1 INDAN-1,3-DIONE AND INDAN-1,2,3-TRIONE DERIVATIVES, PROCESSES FOR PREPARATION OF SAME AND THEIR USE AS THERAPEUTIC AGENTS INNOTHERA (FR) 1993-10-14 WO disclosed